Gregory Korbel
Director de Operaciones en Atrin Pharmaceuticals, Inc. .
Fortuna: 5 741 $ al 30/04/2024
Cargos activos de Gregory Korbel
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Atrin Pharmaceuticals, Inc.
Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile. | Director de Operaciones | - | - |
Historial de carrera de Gregory Korbel
Antiguos cargos conocidos de Gregory Korbel.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
APREA THERAPEUTICS, INC. | Director de Operaciones | 01/05/2022 | 31/03/2023 |
Corporate Officer/Principal | 01/07/2016 | 01/05/2022 | |
Novira Therapeutics LLC
Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | Director de Operaciones | 01/08/2012 | 01/12/2015 |
JOHNSON & JOHNSON | Corporate Officer/Principal | - | - |
Formación de Gregory Korbel.
Vanderbilt University | Undergraduate Degree |
Harvard University | Doctorate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Estadísticas
Internacional
Estados Unidos | 8 |
Operativa
Chief Operating Officer | 3 |
Corporate Officer/Principal | 2 |
Undergraduate Degree | 1 |
Sectorial
Health Technology | 5 |
Consumer Services | 4 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
APREA THERAPEUTICS, INC. | Health Technology |
JOHNSON & JOHNSON | Health Technology |
Empresas privadas | 2 |
---|---|
Novira Therapeutics LLC
Novira Therapeutics LLC Pharmaceuticals: MajorHealth Technology Novira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the discovery and development of therapies for the treatment of chronic hepatitis B (CHB) infection. The firm’s novel antiviral drug candidates addresses the limitations of CHB therapies. The company was founded in 2009 by Osvaldo Flores, Ali Munawar and George D. Hartman and is headquartered in Doylestown, PA. | Health Technology |
Atrin Pharmaceuticals, Inc.
Atrin Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Founded in 2012, Atrin Pharmaceuticals, Inc. is a DNA Damage Response development company that focuses on a pipeline of products resulting from a series of novel conformationally restricted macrocyclic molecules. Part of Aprea Therapeutics, Inc., the company is based in Doylestown, PA. Atrin Pharmaceuticals was acquired by Aprea Therapeutics, Inc. on May 16, 2022 for $1.33 million. The company's products have the highest known potency for inhibiting ATR and exhibit ATR selectivity with potential broad therapeutic profile. | Health Technology |
- Bolsa de valores
- Insiders
- Gregory Korbel
- Experiencia